H. Lundbeck A/S (LON:0ABR)
London · Delayed Price · Currency is GBP · Price in DKK 37.15
-1.80 (-4.62%)
At close: Jan 28, 2026
Revenue by Product
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | 1988 - 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 | Dec '07 Dec 31, 2007 | Dec '06 Dec 31, 2006 | Dec '05 Dec 31, 2005 | 1988 - 2004 |
Rexulti | 5.20B | Upgrade | |||||||||||||||||||
Rexulti Growth | 14.96% | Upgrade | |||||||||||||||||||
Brintellix/Trintellix | 4.85B | Upgrade | |||||||||||||||||||
Brintellix/Trintellix Growth | 12.10% | Upgrade | |||||||||||||||||||
Abilify Long-acting Injectable Franchise | 3.50B | Upgrade | |||||||||||||||||||
Abilify Long-acting Injectable Franchise Growth | 9.95% | Upgrade | |||||||||||||||||||
Other Pharmaceuticals | 3.18B | Upgrade | |||||||||||||||||||
Other Pharmaceuticals Growth | -1.97% | Upgrade | |||||||||||||||||||
Vyepti | 2.91B | Upgrade | |||||||||||||||||||
Vyepti Growth | 71.42% | Upgrade | |||||||||||||||||||
Cipralex/Lexapro | 2.05B | Upgrade | |||||||||||||||||||
Cipralex/Lexapro Growth | -4.07% | Upgrade | |||||||||||||||||||
Reconciling Items | 366.00M | Upgrade | |||||||||||||||||||
Reconciling Items Growth | 11.93% | Upgrade | |||||||||||||||||||
Exceptional Items | -52.00M | Upgrade | |||||||||||||||||||
Exceptional Items Growth | -137.96% | Upgrade | |||||||||||||||||||
Reconciling Items | 366.00M | Upgrade | |||||||||||||||||||
Reconciling Items Growth | 11.93% | Upgrade | |||||||||||||||||||
Exceptional Items | -52.00M | Upgrade | |||||||||||||||||||
Exceptional Items Growth | -137.96% | Upgrade |
Revenue by Geography
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | 1988 - 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 | Dec '07 Dec 31, 2007 | Dec '06 Dec 31, 2006 | Dec '05 Dec 31, 2005 | 1988 - 2004 |
Reconciling Items | 366.00M | Upgrade | |||||||||||||||||||
Reconciling Items Growth | 11.93% | Upgrade | |||||||||||||||||||
Exceptional Items | -52.00M | Upgrade | |||||||||||||||||||
Exceptional Items Growth | -137.96% | Upgrade | |||||||||||||||||||
United States | 11.33B | Upgrade | |||||||||||||||||||
United States Growth | 15.22% | Upgrade | |||||||||||||||||||
International | 5.22B | Upgrade | |||||||||||||||||||
International Growth | 4.57% | Upgrade | |||||||||||||||||||
Europe | 5.13B | Upgrade | |||||||||||||||||||
Europe Growth | 11.21% | Upgrade | |||||||||||||||||||
Reconciling Items | 366.00M | Upgrade | |||||||||||||||||||
Reconciling Items Growth | 11.93% | Upgrade | |||||||||||||||||||
Denmark | 15.00M | Upgrade | |||||||||||||||||||
Denmark Growth | 7.14% | Upgrade | |||||||||||||||||||
Exceptional Items | -52.00M | Upgrade | |||||||||||||||||||
Exceptional Items Growth | -137.96% | Upgrade |